![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: Under the liquidity contract entered into between MEDINCELL (Paris:MEDCL) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2024:...
Regulatory News: Medincell (Paris:MEDCL) will provide an overview of some of its R&D programs related to its cutting-edge Long-Acting Injectable technologies through several presentations and...
H.C. Wainwright & Co.’s research department, one of the leading players in the U.S. Healthcare sector, has initiated coverage of Medincell H.C. Wainwright & Co. equity research team led...
Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: Medincell (Paris:MEDCL) : Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605...
Regulatory News: Medincell (Paris:MEDCL): Indice de référence du secteur de la tech en Europe, Euronext Tech Leaders regroupe plus de 120 entreprises technologiques à forte croissance et de...
(1er avril 2023 - 31 mars 2024) Regulatory News: Medincell (Paris:MEDCL): Faits marquants Lancement de la commercialisation aux Etats-Unis de UZEDY® (rispéridone) par Teva Pharmaceuticals...
Regulatory News : Medincell (Paris:MEDCL) tiendra une vidéoconférence le lundi 10 juin 2024 à 14h00 pour présenter les résultats annuels de l’exercice clos au 31 mars 2024, qui seront publiés le...
Regulatory News: Medincell (Paris:MEDCL): Teva a présenté sept études de son programme de recherche sur les antipsychotiques à action prolongée pour la schizophrénie lors du Psych Congress...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.64 | 4.28954423592 | 14.92 | 16.2 | 14.76 | 57725 | 15.80569609 | DE |
4 | 1.88 | 13.7426900585 | 13.68 | 16.2 | 13.04 | 58932 | 14.81147299 | DE |
12 | 1.18 | 8.20584144645 | 14.38 | 17.5 | 12.68 | 96318 | 14.73042494 | DE |
26 | 7.32 | 88.8349514563 | 8.24 | 17.5 | 8.08 | 85110 | 12.86618842 | DE |
52 | 9.17 | 143.505477308 | 6.39 | 17.5 | 5.25 | 65767 | 10.7008326 | DE |
156 | 6.46 | 70.989010989 | 9.1 | 17.5 | 4.73 | 45517 | 9.09278402 | DE |
260 | 8.58 | 122.922636103 | 6.98 | 20 | 4.35 | 42440 | 9.75866237 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions